Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients

Internal Medicine

Volumn 38, Issue 6, 1999, Pages 472-475

  Kuwabara, Satoshi ^b   Nakazawa, Ryoichi ^a   Azuma, Nakanobu ^a   Suzuki, Mitsuru ^a   Miyajima, Keiko ^a   Fukutake, Toshio ^b   Hattori, Takamichi ^b  

^a Tokatsu Clinic Hospital   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nerve regeneration; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; MECOBALAMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR NERVE CONDUCTION; PAIN ASSESSMENT; SENSORY NERVE CONDUCTION; TREATMENT OUTCOME; UREMIC POLYNEUROPATHY; VITAMIN BLOOD LEVEL;

EID: 0032772437     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.472     Document Type: Article

References (17)

1. Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol 8: 413-428, 1963.
2. Thomas PK. Screening for peripheral neuropathy in patients treated by chronic hemodialysis. Muscle Nerve 1: 396-399, 1978.
3. Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 7: 89-96, 1980.
4. Thomas PK, Hollinrake K, Lascelles RG, et al. The polyneuropathy of chronic renal failure. Brain 94: 761-780, 1971.
5. Asbury AK. Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency, and critical illness. in: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, Eds. Peripheral Neuropathy. WB Saunders, Philadelphia, 1993: 1251-1257.
6. Nielsen VK. The peripheral nerve function in chronic renal failure. 2. Intercorrelation of clinical symptoms and signs and clinical grading of neuropathy. Acta Med Scand 190: 113-117, 1971.
7. Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci 122: 140-143, 1994.
8. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11: 136-141, 1982.
9. Dyck PJ, Lambert EH, O'Brien PC. Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 26: 466-471, 1976.
10. Seckel BR. Enhancement of peripheral nerve regeneration. Muscle Nerve 13: 785-800, 1990.
11. Cedar H. DNA methylation and gene activity. Cell 53: 3-4, 1988.
12. Pfohl-Leszkowicz A, Keith G, Dirheimer G. Effect of cobalamin derivatives on in vitro enzymatic DNA methylation: methylcobalamin can act as a methyl donor. Biochemistry 30: 8045-8051, 1991.
13. Atsuta Y, Iwahara T, Sugawara O, Muramoto T, Watakabe T, Takemitsu Y. The study of generating and suppressive factors of ectopic firing in the lumbar dorsal root using an in vitro model. Clinical Orthopedics 29: 441-446, 1994 (Abstract in English).
14. Kuwabara S, Kamoshita H, Taketani T, Nakajima M, Hirayama K. The effect of intravenous injection of methyl-B 12 on neuropathic pain/paresthesia. Neurological Therapeutics 10: 341-344, 1993 (Abstract in English).
15. Taniguchi T, Ejiri K, Baba S. Improvement of autonomic neuropathy after mecobalamin treatment in uremic patients on hemodialysis. Clin Ther 9: 607-614, 1987.
16. Koyama K, Yoshida A, Takeda AK, Morozumi K, Fujinami T. Efficacy of methylcobalamin in subclinical uraemic neuropathy as detected by measuring vibration perception thresholds. Nephrology 2: 25-28, 1996.
17. Ogawa T, Tomono Y, Morishita N, Shishido R. Pharmacokinetics of injected mecobalamin in healthy adults: Intravenous and intramuscular routes. Vitamins 63: 123-130, 1989 (Abstract in English).